Last reviewed · How we verify

NCT05449210

Urdu Version of Parkinson's Disease Questionnaire: Reliability and Validity Study

Completed Last updated 17 January 2023
What this trial tests

trial in Quality of Life in 195 participants. Completed in 28 July 2022.

Timeline
1 May 2021
Primary endpoint
25 July 2022
28 July 2022

Quick facts

Lead sponsorRiphah International University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment195
Start date1 May 2021
Primary completion25 July 2022
Estimated completion28 July 2022
Sites1 location across Pakistan

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 30 to 80, any sex, with Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the study , the researchers will investigate the reliability and validity of Urdu version Parkinson's Disease Questionnaire in Pakistani population having Parkinsonism

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Quality of Life

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05449210.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing